SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Exelixis, Inc. (EXEL)
An SI Board Since January 2001
Posts SubjectMarks Bans Symbol
930 66 0 EXEL
Emcee:  kinkblot Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
830Yeah, but by the time they get to that point, a few will have passed on , and thtuck111/9/2011
829<i>the commercial opportunity is smaller</i> Not clear to me - pretBiomaven111/9/2011
828We won't know till the fat lady starts singing about whether or not BMY madetuck-11/6/2011
827Hammer’s latest blog on EXEL (“Setting the Facts Straight”): siliconinvestor.coDewDiligence_on_SI-11/6/2011
826so was BMY right to give it back?mopgcw-11/6/2011
825Exelixis, Inc. (EXEL) Special Conference Call October 31, 2011 6:00 PM ET Charlmopgcw-11/6/2011
824abstractsonline.com (Easier to read using the link) Presentation Session A90/AIRWIN JAMES FRANKEL-11/5/2011
823Indeed. Well, I took my 20 cents/share and ran an hour ago. Will definitely betuck-11/3/2011
822One no longer need look at Twitter, to tell which bit of dogma the twits have gascaram(o)uche-11/3/2011
821That's a good question. Seems to have been quietly halted. I presume becautuck-11/3/2011
820Sorry, didn't see that you had put up a post before I did. You were certainscaram(o)uche-11/2/2011
819From Earnie on Yahoo: Re: no SPA means 1-Nov-11 07:44 am Ugly day. First. ItIRWIN JAMES FRANKEL-11/1/2011
818Twits going nuts. <b>No SPA</b>, company proceeding with '306 trscaram(o)uche-10/31/2011
817EXEL couldn't reach agreement on the SPA, is going ahead without one. Thinktuck-10/31/2011
816Possible competition for Cabozantinib – Radium 223 Message 27736133tnsaf-10/30/2011
815Exelixis's CEO Discusses Q3 2011 Results - Earnings Call Transcript OctoberIRWIN JAMES FRANKEL-10/28/2011
814YM - Earnie commenting in response to: <<If the EXAM trial included patieIRWIN JAMES FRANKEL-10/24/2011
813Exelixis’ Cabozantinib Meets Primary Endpoint in Phase 3 Clincial Trial for MeduIRWIN JAMES FRANKEL-10/24/2011
812Conference call is scheduled for the 27th. I'm wondering what exactly are thewolf-10/20/2011
811I am on hold for EXEL. Still buying some others. ijIRWIN JAMES FRANKEL-10/3/2011
810So, the market has collapsed. Exel stock price painfully down. Report on mtc is ewolf-10/3/2011
809Perhaps this is a comment on their EXEL rating... 08:53 am Jefferies Group downIan@SI-9/21/2011
808anyone with details on the jefferies hold initiation?ewolf-9/20/2011
807Relevant to EXEL on pain as a clinical trial endpoint: End Points and Outcomesidos-9/19/2011
806Per AF's comments, looks like good MTC results are imminent... Exelixis ReaIan@SI-9/7/2011
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News